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Background
Pancreatic cancer is characterized by the presence of a
highly reactive stroma [1]. The latter harbors a variety of
cellular compartments including stellate cells, fibroblasts,
endothelial cells and a variety of inflammatory cells such
as macrophages and monocytes. Interaction between
tumour cells and surrounding stromal cells (tumour
micro- environment) plays an important role in pancreatic
cancer progression [2]. We have previously shown that
stroma-associated monocytes express low molecular
weight proteins: S100A8 and S100A9 [3]. The aim of this
study is to investigate the involvement of S100A8 and
S100A9 proteins in the tumour-stroma crosstalk and to
decipher the potential signaling mechanism.
Materials and methods
Cell culture of pancreatic cancer cells and monocytic
cells, HL-60 and primary isolated human monocytes.
Isolation of Conditioned medias from pancreatic cancer
cells. Western blotting analysis. Cytokines multiplexing
assay (27-plex, BioRad). Cell signaling assay. Luciferase
assay.
Results
1- The expression of S100A8 and S100A9 in mono-
cytes is increased in response to soluble factors in pan-
creatic cancer cells conditioned media.
2- Cytokine profiling of cell supernatants, using Lumi-
nex assay, showed that PCC secrete a number of cyto-
kines and growth factors including IL-8, FGF and TNF-a.
3- S100A8 and S100A9 increased phosphorylation of
MAPK, erk1/2 and p38 and activated NF-kB signaling
pathways in a RAGE dependent manner.
Conclusions
S100A8 and S100A9 promote specific cytokine secretion
from pancreatic cancer cells. Interestingly, a number of
these cytokines, in turn, induce the secretion of S100A8
and S100A9 from monocytic cells, creating a paracrine
loop. These events may create a favourable environment
for tumour development and metastases.
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